ALX-804-621-C100

antibody from Enzo Life Sciences

Targeting: ITGA6 CD49f

Immunoprecipitation (Recommended by provider)

Immunohistochemistry (Recommended by provider)

Flow cytometry (Recommended by provider)

Antibody Data

Product number

ALX-804-621-C100

Provider

Enzo Life Sciences

Proper citation

Enzo Life Sciences Cat#ALX-804-621-C100, RRID:AB_2051081

Product name

CD49f (human) monoclonal antibody (MAR6)

Antibody type

Monoclonal

Antigen

Recombinant full length protein

Reactivity

Human

Host

Mouse

Isotype

IgG

Antibody clone number

MAR6

Vial size

100 μg

Storage

+4°C

Handling

Do not freeze.

References

Submitted references

Gorham-Stout syndrome: a monocyte-mediated cytokine propelled disease.

Colucci S, Taraboletti G, Primo L, Viale A, Roca C, Valdembri D, Geuna M, Pagano M, Grano M, Pogrel AM, Harris AL, Athanasou NN, Mantovani A, Zallone A, Bussolino F
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2006 Feb;21(2):207-18

---

Differential expression and topography of adhesion molecules in laryngeal and oropharyngeal carcinomas.

Ricci E, Cavalot AL, Sanvito F, Bussi M, Albera R, Staffieri A, Cortesina G, Marchisio PC
Acta oto-laryngologica 2002 Mar;122(2):234-40

---

Transforming growth factor-beta1 triggers hepatocellular carcinoma invasiveness via alpha3beta1 integrin.

Giannelli G, Fransvea E, Marinosci F, Bergamini C, Colucci S, Schiraldi O, Antonaci S
The American journal of pathology 2002 Jul;161(1):183-93

---

SEL1L expression decreases breast tumor cell aggressiveness in vivo and in vitro.

Orlandi R, Cattaneo M, Troglio F, Casalini P, Ronchini C, Ménard S, Biunno I
Cancer research 2002 Jan 15;62(2):567-74

---

Human hepatocellular carcinoma (HCC) cells require both alpha3beta1 integrin and matrix metalloproteinases activity for migration and invasion.

Giannelli G, Bergamini C, Fransvea E, Marinosci F, Quaranta V, Antonaci S
Laboratory investigation; a journal of technical methods and pathology 2001 Apr;81(4):613-27

---

Prognostic value of alpha 6 beta 4 integrin expression in breast carcinomas is affected by laminin production from tumor cells.

Tagliabue E, Ghirelli C, Squicciarini P, Aiello P, Colnaghi MI, Ménard S
Clinical cancer research : an official journal of the American Association for Cancer Research 1998 Feb;4(2):407-10

---

Growth factor-dependent activation of alphavbeta3 integrin in normal epithelial cells: implications for tumor invasion.

Trusolino L, Serini G, Cecchini G, Besati C, Ambesi-Impiombato FS, Marchisio PC, De Filippi R
The Journal of cell biology 1998 Aug 24;142(4):1145-56

---

Co-regulation and physical association of the 67-kDa monomeric laminin receptor and the alpha6beta4 integrin.

Ardini E, Tagliabue E, Magnifico A, Butò S, Castronovo V, Colnaghi MI, Ménard S
The Journal of biological chemistry 1997 Jan 24;272(4):2342-5

---

Membrane vesicles shed into the extracellular medium by human breast carcinoma cells carry tumor-associated surface antigens.

Dolo V, Adobati E, Canevari S, Picone MA, Vittorelli ML
Clinical & experimental metastasis 1995 Jul;13(4):277-86

---

Polarization of the alpha 6 beta 4 integrin in ovarian carcinomas.

Bottini C, Miotti S, Fiorucci S, Facheris P, Ménard S, Colnaghi MI
International journal of cancer 1993 May 8;54(2):261-7